By Jeff Montgomery ( February 8, 2023, 4:18 PM EST) -- Former Viela Bio Inc. stockholders have sued ex-company parent AstraZeneca PLC, its UK Ltd. affiliate and key figures of both companies in Delaware's Court of Chancery over a purportedly underpriced $3 billion sale of Viela that allegedly subordinated its interests to AstraZeneca's pursuit of a bigger deal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.